New Targets = Better Standard of Care

Alexander Bastian
Video Categories: Targeted Therapies

Alexander Bastian mentions that looking at more defined populations and leveraging the power of targeted medicine is improving the standard of care.
April 14, 2015

Unclear Diagnoses in Patients with Metastatic Disease

Dr. Boccia addresses the problem of unclear diagnoses affecting approximately 15% of newly diagnosed patients with metastatic disease each year and the importance of an accurate diagnosis of tumor type in selecting the proper site-specific therapies.

January 13, 2015

BCI Affects and Survivorship

Dr Susan K. Boolbol talks about the importance of objective evidence provided by the Breast Cancer IndexSM (BCI) in treatment decision making.